Navigation Links
Atlas Appoints David Whitaker as Operations Director

BATH, England, November 27, 2013 /PRNewswire/ --

Atlas Genetics Ltd ("Atlas" or the "Company"), a diagnostic company developing ultra-rapid point-of-care tests for a range of infectious diseases, today announces the appointment of David Whitaker as Operations Director with immediate effect.

David joins Atlas from DNA Electronics, where he worked as Manufacturing & Mechanical Engineering Manager, responsible for the development of a fully portable, point-of-care genetic test device.  This project involved a wide range of technical disciplines including microfluidics, electronics and molecular biology.  He worked closely with the acting Chief Scientific Officer on the overall management of the project and held direct responsibility for all device engineering activities.  

Prior to this, he spent five years as a Principal Consultant in PA Consulting's Technology and Innovation Practice.  During his tenure, he successfully developed and patented a range of medical devices for both big pharma and start-up companies.  Before joining PA Consulting, David worked in a variety of medical device engineering, contract engineering and consulting positions at companies including Ivax Pharmaceuticals, Futura Medical West Pharmaceuticals and Risdon Pharma.

David has First Class BEng degree in Mechanical & Manufacturing Engineering with Management from the University of Leeds.

Dr John Clarkson, Chief Executive Officer of Atlas, commented: "At Atlas, we have worked hard over the past year to enhance and develop our senior management team.  David brings considerable operational expertise which will be important as we enter a new phase of product manufacture and growth, further progressing Atlas towards becoming a first class diagnostics company."

About Atlas (

Atlas (Atlas Genetics Ltd) develops ultra-rapid point-of-care (POC) diagnostic tests for infectious diseases.  The Atlas io™ system uses patented technology based on the use of a novel electrochemical sensor that combines speed, accuracy and multiplex detection capability.  The Company has its head office and laboratory facilities near Bath.  Atlas was established in 2005 and is financed by VC, corporate and private investors including Consort Medical plc, Novartis Venture Funds, J&J Development Corporation, Life Science Partners (LSP), BB Biotech Ventures and YFM Equity Partners.  The company raised £16.9 million in series B finance in 2011.

The Atlas io™ platform

POC diagnostics offer health professionals the ability to test for medical conditions at the site of patient care.  Atlas has developed the io™ system, a flexible POC technology platform, which has been designed to accurately and quickly diagnose a wide range of medical conditions within 30 minutes.  The Atlas io™ system consists of an inexpensive test machine into which a disposable cartridge containing a patient sample is inserted.  The io™ platform is scheduled for clinical trials in 2014, followed by rollout in Europe and the United States, pending regulatory approvals.

Atlas is developing tests for a range of infectious diseases including sexually transmitted infections and hospital acquired infections.  The io™ system will initially be launched for the rapid testing of Chlamydia, allowing clinicians to test and treat patients in a single visit.  Around 40 million tests are carried out for these diseases in Europe and the US every year.  According to the European Centre for Disease Prevention and Control, Chlamydia is the most frequently reported bacterial Sexually Transmitted Infection (STI), with prevalence rates in young people between 5-10%, whilst Gonorrhoea is the second most commonly 'reported' STI.  An increasing awareness, number of reported cases and increased testing for Gonorrhoea, Trichomonasvaginalis and Mycoplasma genitalium infection means these are a logical extension to the STI test menu for the io™ platform.  The worldwide in vitro diagnostic market for infectious disease testing is estimated to be worth around US$9 billion.

Contact details:

Atlas Genetics Ltd:    
John Clarkson    
Tel: +44(0)1225-717930
FTI Consulting:    
Mo Noonan / Ben Atwell    
Tel: +44(0)207-831-3113

SOURCE Atlas Genetics Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Roka Bioscience Atlas System For Food Pathogen Detection Integrated At Department of Defense Food Analysis and Diagnostic Laboratory
2. Proteome atlas for the tuberculosis pathogen
3. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
4. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
5. Roka Bioscience Kicks Off Atlas on Tour, a Mobile Demonstration Vehicle for the Food Safety Industry, at IAFP
6. CMDBioscience Appoints Tomi Sawyer to Scientific Advisory Board; Entrepreneurial Drug Hunter and Distinguished Scholar Named as Founding Chair
7. Boston Biomedical Appoints Patricia S. Andrews as Chief Commercial Officer
8. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
9. Convoy Therapeutics Appoints Clinical Advisory Board
10. Egenix, Inc. Appoints Matthew Fury, M.D., Ph.D. to its Scientific Advisory Committee
11. Metamark Appoints Cornelius J. Merlini Chief Commercial Officer
Post Your Comments:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
Breaking Biology Technology:
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
Breaking Biology News(10 mins):